A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML)

Clinical trial NCT04161885 · TERMINATED

Trial details

NCT number: NCT04161885
Sponsor: AbbVie
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)Cancer

Start date: 2020-02-26
Primary completion: 2025-09-23
Enrollment: 465

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.